Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaycee M Sink

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Stroke|January 17, 2013
Pulse wave velocity and cognitive decline in elders: the Health, Aging, and Body Composition studyAdina Zeki Al Hazzouri, Anne B Newman, Eleanor Simonsick, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|December 6, 2018
The Association between the Montreal Cognitive Assessment and Functional Activity Questionnaire in the Systolic Blood Pressure Intervention Trial (SPRINT)Carolyn H Still, Nicholas M Pajewski, Gordon J Chelune, et al.
Gerontology & Geriatrics Education|June 7, 2014
Utilizing a Meals on Wheels program to teach falls risk assessment to medical studentsJamehl L Demons, Swapna Chenna, Kathryn E Callahan, et al.
Archives of Internal Medicine|July 15, 2009
Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health StudyKaycee M Sink, Xiaoyan Leng, Jeff Williamson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 21, 2013
Cognitive factors associated with adherence to oral antiestrogen therapy: results from the cognition in the study of tamoxifen and raloxifene (Co-STAR) studyHeidi D Klepin, Ann M Geiger, Hanna Bandos, et al.
International Journal of Geriatric Psychiatry|January 14, 2011
Telephone interview for cognitive status (TICS) screening for clinical trials of physical activity and cognitive training: the seniors health and activity research program pilot (SHARP-P) studyMark A Espeland, Stephen R Rapp, Jeff A Katula, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 29, 2023
Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerationsRonald C Petersen, Ana Graf, Chris Brady, et al.
BMC Geriatrics|May 28, 2011
Designing clinical trials for assessing the effects of cognitive training and physical activity interventions on cognitive outcomes: the Seniors Health and Activity Research Program Pilot (SHARP-P) study, a randomized controlled trialClaudine Legault, Janine M Jennings, Jeffrey A Katula, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 22, 2012
Cerebral white matter hyperintensity in African Americans and European Americans with type 2 diabetesJasmin Divers, Christina Hugenschmidt, Kaycee M Sink, et al.
Journal of Alzheimer'S Disease : JAD|June 23, 2020
Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 WeeksHeather Guthrie, Lawrence S Honig, Helen Lin, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Stroke|January 17, 2013
Pulse wave velocity and cognitive decline in elders: the Health, Aging, and Body Composition studyAdina Zeki Al Hazzouri, Anne B Newman, Eleanor Simonsick, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|December 6, 2018
The Association between the Montreal Cognitive Assessment and Functional Activity Questionnaire in the Systolic Blood Pressure Intervention Trial (SPRINT)Carolyn H Still, Nicholas M Pajewski, Gordon J Chelune, et al.
Gerontology & Geriatrics Education|June 7, 2014
Utilizing a Meals on Wheels program to teach falls risk assessment to medical studentsJamehl L Demons, Swapna Chenna, Kathryn E Callahan, et al.
Archives of Internal Medicine|July 15, 2009
Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health StudyKaycee M Sink, Xiaoyan Leng, Jeff Williamson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 21, 2013
Cognitive factors associated with adherence to oral antiestrogen therapy: results from the cognition in the study of tamoxifen and raloxifene (Co-STAR) studyHeidi D Klepin, Ann M Geiger, Hanna Bandos, et al.
International Journal of Geriatric Psychiatry|January 14, 2011
Telephone interview for cognitive status (TICS) screening for clinical trials of physical activity and cognitive training: the seniors health and activity research program pilot (SHARP-P) studyMark A Espeland, Stephen R Rapp, Jeff A Katula, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 29, 2023
Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerationsRonald C Petersen, Ana Graf, Chris Brady, et al.
BMC Geriatrics|May 28, 2011
Designing clinical trials for assessing the effects of cognitive training and physical activity interventions on cognitive outcomes: the Seniors Health and Activity Research Program Pilot (SHARP-P) study, a randomized controlled trialClaudine Legault, Janine M Jennings, Jeffrey A Katula, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 22, 2012
Cerebral white matter hyperintensity in African Americans and European Americans with type 2 diabetesJasmin Divers, Christina Hugenschmidt, Kaycee M Sink, et al.
Journal of Alzheimer'S Disease : JAD|June 23, 2020
Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 WeeksHeather Guthrie, Lawrence S Honig, Helen Lin, et al.
Pageof 9